Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 2, Human | 1 | 2021 | 191 | 0.680 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2017 | 17 | 0.590 |
Why?
|
| Herpes Simplex | 1 | 2021 | 478 | 0.590 |
Why?
|
| Skin Neoplasms | 4 | 2018 | 5799 | 0.580 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2018 | 167 | 0.550 |
Why?
|
| Microscopic Polyangiitis | 1 | 2016 | 46 | 0.530 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2016 | 42 | 0.530 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2016 | 70 | 0.500 |
Why?
|
| Penis | 1 | 2016 | 212 | 0.490 |
Why?
|
| Penile Neoplasms | 1 | 2016 | 162 | 0.480 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2016 | 288 | 0.460 |
Why?
|
| Immunoglobulin A | 2 | 2016 | 979 | 0.440 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 560 | 0.430 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2016 | 517 | 0.400 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2145 | 0.390 |
Why?
|
| Skin | 5 | 2022 | 4466 | 0.350 |
Why?
|
| Neoplasms, Second Primary | 1 | 2018 | 1056 | 0.350 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.340 |
Why?
|
| Interleukin-17 | 3 | 2022 | 910 | 0.330 |
Why?
|
| Pemphigus | 2 | 2023 | 116 | 0.320 |
Why?
|
| Psoriasis | 3 | 2022 | 940 | 0.280 |
Why?
|
| Skin Diseases | 1 | 2014 | 1089 | 0.260 |
Why?
|
| Dermatitis | 2 | 2018 | 200 | 0.260 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2532 | 0.260 |
Why?
|
| Werner Syndrome | 1 | 2023 | 12 | 0.230 |
Why?
|
| Panniculitis | 1 | 2023 | 45 | 0.220 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 105 | 0.210 |
Why?
|
| Azathioprine | 1 | 2023 | 356 | 0.200 |
Why?
|
| Crohn Disease | 1 | 2014 | 2275 | 0.200 |
Why?
|
| Sjogren's Syndrome | 1 | 2023 | 235 | 0.200 |
Why?
|
| Choristoma | 1 | 2023 | 207 | 0.200 |
Why?
|
| Chemokine CXCL12 | 1 | 2021 | 454 | 0.160 |
Why?
|
| Melanoma | 1 | 2017 | 5697 | 0.160 |
Why?
|
| Thromboxane A2 | 1 | 2018 | 90 | 0.150 |
Why?
|
| Physical Conditioning, Animal | 1 | 2021 | 366 | 0.140 |
Why?
|
| Melanoma, Amelanotic | 1 | 2016 | 19 | 0.140 |
Why?
|
| Syringoma | 1 | 2016 | 8 | 0.140 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2016 | 15 | 0.140 |
Why?
|
| Indazoles | 1 | 2018 | 302 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 728 | 0.130 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2015 | 8 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2016 | 107 | 0.130 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2018 | 244 | 0.130 |
Why?
|
| Histiocytosis | 1 | 2015 | 40 | 0.120 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2015 | 42 | 0.120 |
Why?
|
| Immunity | 1 | 2021 | 998 | 0.120 |
Why?
|
| Skin Diseases, Genetic | 1 | 2015 | 49 | 0.120 |
Why?
|
| Colchicine | 1 | 2016 | 261 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 680 | 0.120 |
Why?
|
| Raynaud Disease | 1 | 2015 | 79 | 0.120 |
Why?
|
| Models, Animal | 1 | 2021 | 2117 | 0.120 |
Why?
|
| Groin | 1 | 2014 | 107 | 0.120 |
Why?
|
| Interferon-beta | 1 | 2016 | 345 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 1791 | 0.110 |
Why?
|
| Contracture | 1 | 2015 | 235 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2023 | 2325 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12965 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10181 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 781 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2018 | 1977 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2018 | 2560 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22023 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3529 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 2053 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 3016 | 0.070 |
Why?
|
| Humans | 16 | 2023 | 760621 | 0.060 |
Why?
|
| Exercise | 1 | 2021 | 5787 | 0.060 |
Why?
|
| Biopsy | 1 | 2016 | 6771 | 0.060 |
Why?
|
| Male | 9 | 2023 | 359744 | 0.050 |
Why?
|
| Adult | 5 | 2023 | 219994 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2022 | 197 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65017 | 0.040 |
Why?
|
| Mice | 3 | 2022 | 81208 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 755 | 0.040 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Middle Aged | 6 | 2018 | 220352 | 0.040 |
Why?
|
| Thromboxane-A Synthase | 1 | 2018 | 34 | 0.040 |
Why?
|
| Living Donors | 1 | 2023 | 636 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2017 | 63 | 0.040 |
Why?
|
| Aftercare | 1 | 2023 | 916 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 137 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2017 | 420 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 40165 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 167963 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 169152 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 345 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21025 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18137 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 1932 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2022 | 14372 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 1869 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2015 | 348 | 0.030 |
Why?
|
| Breast | 1 | 2023 | 1963 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 2210 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2017 | 792 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2015 | 564 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13630 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3804 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36290 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 4166 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1245 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1788 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3476 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 58741 | 0.020 |
Why?
|
| Neutrophils | 1 | 2022 | 3767 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4122 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 3280 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4925 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4035 | 0.020 |
Why?
|
| Child | 1 | 2016 | 79806 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5745 | 0.020 |
Why?
|
| Female | 4 | 2023 | 391270 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2566 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2017 | 3539 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4541 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10756 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11903 | 0.010 |
Why?
|
| Obesity | 1 | 2017 | 12922 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80372 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58995 | 0.010 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_